Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T15:25:56.646Z.
Calculation as of: 2026-10-06T15:25:56.646Z.
Quote observation: 2026-10-06T15:25:31.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d9de0dbfadb283a207fe687abae4d6c7414f83280ed3d33a9edf26fe3e5e7dd3
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2015-01-30.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$798.38M
EV/EBITDA Ratio
N/A
TTM Avg
76.03x
3Y Avg
57.10x
5Y Avg
57.10x
Market Cap
$789.92M
EV/EBITDA Ratio
6.64x
TTM Avg
5.45x
3Y Avg
14.30x
5Y Avg
12.03x
Market Cap
$789.07M
EV/EBITDA Ratio
N/A
TTM Avg
800.36x
3Y Avg
800.36x
5Y Avg
800.36x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ardelyx, Inc. (ARDX) | $823.84M | N/A | N/A | N/A | N/A |
| Jade Biosciences, Inc. (JBIO)vs › | $834.39M | N/A | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $804.16M | 5.90x | 7.11x | 8.26x | 13.78x |
| Apnimed, Inc. (APMD)vs › | $802.04M | N/A | N/A | N/A | N/A |
| Beta Bionics, Inc. (BBNX)vs › | $841.19M | N/A | N/A | N/A | N/A |
| Gyre Therapeutics, Inc. (GYRE)vs › | $798.38M | N/A | 76.03x | 57.10x | 57.10x |
| Alumis Inc. (ALMS)vs › | $843.76M | N/A | N/A | N/A | N/A |
| AdaptHealth Corp. (AHCO)vs › | $789.92M | 6.64x | 5.45x | 14.30x | 12.03x |
| Geron Corporation (GERN)vs › | $789.07M | N/A | 800.36x | 800.36x | 800.36x |
| Pacific Biosciences of California, Inc. (PACB)vs › | $844.84M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2015-01-30 | 8.85x |
| 2015-01-29 | 9.74x |
| 2015-01-28 | 9.94x |
| 2015-01-27 | 5.88x |
| 2015-01-26 | 6.77x |
| 2015-01-23 | 7.96x |
| 2015-01-22 | 7.17x |
| 2015-01-21 | 3.90x |
| 2015-01-20 | 4.89x |
| 2015-01-16 | 5.29x |
| 2015-01-15 | 2.12x |
| 2015-01-14 | 2.22x |
| 2015-01-13 | 0.93x |
| 2015-01-12 | 0.83x |
| 2015-01-09 | 0.24x |
| 2015-01-08 | 0.34x |
| 2014-12-22 | 1.23x |
| 2014-12-19 | 1.13x |
| 2014-12-18 | 1.53x |
| 2014-12-17 | 0.04x |
| 2014-12-12 | 17.17x |
| 2014-12-11 | 12.52x |
| 2014-12-10 | 13.21x |
| 2014-12-09 | 16.68x |
| 2014-12-08 | 18.46x |
| 2014-12-05 | 23.31x |
| 2014-12-04 | 23.11x |
| 2014-12-03 | 23.41x |
| 2014-12-02 | 14.30x |
| 2014-12-01 | 10.83x |
| 2014-11-28 | 8.26x |
| 2014-11-26 | 7.07x |
| 2014-11-25 | 1.23x |
| 2014-11-24 | 1.03x |
